Randomized comparison of pazopanib (PAZ) and doxorubicin (DOX) in the first line treatment of metastatic soft tissue sarcoma (STS) in elderly patients (pts): Results of a phase II study (EPAZ) - Grünwald, V; Kunitz, A; Schuler, M K (2018)
(Suppl. 36): Abstr. 11506